A Nomogram Based on Atelectasis/Obstructive Pneumonitis Could Predict the Metastasis of Lymph Nodes and Postoperative Survival of Pathological N0 Classification in Non-small Cell Lung Cancer Patients

被引:6
|
作者
Liu, Yi-Han [1 ]
Wu, Lei-Lei [2 ]
Qian, Jia-Yi [2 ]
Li, Zhi-Xin [2 ]
Shi, Min-Xing [1 ]
Wang, Zi-Ran [3 ]
Xie, Long-Yan [4 ]
Liu, Yu'e [4 ]
Xie, Dong [2 ]
Cao, Wei-Jun [1 ]
机构
[1] Tongji Univ, Dept Resp & Crit Care Med, Shanghai Pulm Hosp, Inst Resp Med,Sch Med, Shanghai 200433, Peoples R China
[2] Tongji Univ, Dept Thorac Surg, Shanghai Pulm Hosp, Sch Med, Shanghai 200433, Peoples R China
[3] 903rd Hosp PLA, Dept Orthoped, Hangzhou 310007, Peoples R China
[4] Tongji Univ, Sch Med, Shanghai 200092, Peoples R China
基金
中国国家自然科学基金;
关键词
atelectasis; lymph node metastasis; NSCLC; nomogram; obstructive pneumonitis; PROGNOSTIC-SIGNIFICANCE; STAGING PROJECT; ATELECTASIS; ASSOCIATION; EDITION;
D O I
10.3390/biomedicines11020333
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The eighth TNM staging system proposal classifies lung cancer with partial or complete atelectasis/obstructive pneumonia into the T2 category. We aimed to develop nomograms to predict the possibility of lymph node metastasis (LNM) and the prognosis for NSCLC based on atelectasis and obstructive pneumonitis. Methods: NSCLC patients over 20 years old diagnosed between 2004 and 2015 were selected from the Surveillance, Epidemiology, and End Results (SEER) database. The nomograms were based on risk factors that were identified by Logistic regression. The area under the receiver operating characteristic (ROC) curve (AUC) was performed to confirm the predictive values of our nomograms. Cox proportional hazards analysis and Kaplan-Meier survival analysis were also used in this study. Results: A total of 470,283 patients were enrolled. Atelectasis/obstructive pneumonitis, age, gender, race, histologic types, grade, and tumor size were defined as independent predictive factors; then, these seven factors were integrated to establish nomograms of LNM. The AUC is 0.70 (95% CI: 0.694-0.704). Moreover, the Cox proportional hazards analysis and Kaplan-Meier survival analysis showed that the scores derived from the nomograms were significantly correlated with the survival of pathological N0 classification. Conclusion: Nomograms based on atelectasis/obstructive pneumonitis were developed and validated to predict LNM and the postoperative prognosis of NSCLC.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients
    Zhang, Fanrong
    Zheng, Weihui
    Ying, Lisha
    Wu, Junzhou
    Wu, Shaoyuan
    Ma, Shenglin
    Su, Dan
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (09) : 3033 - 3039
  • [42] A Nomogram to Predict Brain Metastases of Resected Non-Small Cell Lung Cancer Patients
    Fanrong Zhang
    Weihui Zheng
    Lisha Ying
    Junzhou Wu
    Shaoyuan Wu
    Shenglin Ma
    Dan Su
    Annals of Surgical Oncology, 2016, 23 : 3033 - 3039
  • [43] The utility of endosonography for mediastinal staging of non-small cell lung cancer in patients with radiological N0 disease
    Shin, Sun Hye
    Jeong, Byeong-Ho
    Jhun, Byung Woo
    Yoo, Hongseok
    Lee, Kyungjong
    Kim, Hojoong
    Kwon, O. Jung
    Han, Jungho
    Kim, Jhingook
    Lee, Kyung Soo
    Um, Sang-Won
    LUNG CANCER, 2020, 139 : 151 - 156
  • [44] Treatment outcomes of lobectomy with and without mediastinal lymph node dissection in older patients with clinical N0 non-small cell lung cancer
    Fujita, Tomohiro
    Koyanagi, Akira
    Kishimoto, Koji
    ASIAN CARDIOVASCULAR & THORACIC ANNALS, 2023, 31 (05): : 431 - 438
  • [45] Outcome of Surgical Resection for Pathologic N0 and Nx Non-small Cell Lung Cancer
    Osarogiagbon, Raymond U.
    Allen, Jeffrey W.
    Farooq, Aamer
    Berry, Allen
    Spencer, David
    O'Brien, Thomas
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (02) : 191 - 196
  • [46] A Nomogram to Predict the Overall Survival of Patients With Resected T1-2N0-1M0 Non-Small Cell Lung Cancer and to Identify the Optimal Candidates for Adjuvant Chemotherapy in Stage IB or IIA Non-Small Cell Lung Cancer Patients
    Wang, Wei
    Zhou, Juying
    CANCER CONTROL, 2023, 30
  • [47] A NOMOGRAM TO PREDICT BRAIN METASTASIS AS FIRST RELAPSE SITE IN CURATIVELY RESECTED NON-SMALL CELL LUNG CANCER PATIENTS
    Won, Young-Woong
    Ju, Jungnam
    Kim, So Hee
    Lee, Geon Kook
    Han, Ji-Youn
    Kim, Heung Tae
    Lee, Jin Soo
    Lee, Hyun-Sung
    Kim, Moon Soo
    Lee, Jong Mog
    Zo, Jae Ill
    Yun, Tak
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1249 - S1249
  • [48] Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer
    Xu, Junhao
    Wang, Peiliang
    Li, Yikun
    Shi, Xiaonan
    Yin, Tianwen
    Yu, Jinming
    Teng, Feifei
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [49] A Nomogram to Predict the Survival of Stage IIIA-N2 Non-Small Cell Lung Cancer After Surgery
    Mao, Q.
    Xu, L.
    Jiang, F.
    Yin, R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2374 - S2375
  • [50] Clinical Characteristics and Outcome of Pathologic N0 Non-small Cell Lung Cancer Patients With False Positive Mediastinal Lymph Node Metastasis on FDG PET-CT
    Kim, Kyu Yean
    Park, Hye Lim
    Kang, Hye Seon
    Lee, Hwa Young
    Yoo, Ie Ryung
    Lee, Sang Haak
    Yeo, Chang Dong
    IN VIVO, 2021, 35 (03): : 1829 - 1836